| Description | Venlafaxine (Wy 45030), an arylalkanolamine serotonin-norepinephrine reuptake inhibitor (SNRI), is used to treat major generalised anxiety disorder (GAD), depressive disorder (MDD), panic disorder and social phobia. |
| Synonyms | Wy 45030, 文拉法辛 |
| molecular weight | 277.4 |
| Molecular formula | C17H27NO2 |
| CAS | 93413-69-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 65 mg/mL (234.32 mM), Sonication is recommended. |
| References | 1. Singh J . Venlafaxine: more dangerous than most "selective" serotonergic antidepressants.[J]. prescrire international, 2016, 25(170):96. 2. Wang J L, Wang Y, Gao T T, et al. Venlafaxine protects against chronic stress-related behaviors in mice by activating the mTORC1 signaling cascade[J]. Journal of Affective Disorders. 2020, 276: 525-536. |
| Citations | 1. Wang J L, Wang Y, Gao T T, et al. Venlafaxine protects against chronic stress-related behaviors in mice by activating the mTORC1 signaling cascade. Journal of Affective Disorders. 2020, 276: 525-536. |